From: Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon
Variables | Adjusted OR | 95% CI | P-value |
---|---|---|---|
Hospitalization | |||
Not | 1 | ||
Yes | 0.99 | 1.18–4.00 | 0.01 |
Age | |||
Yes | 0.98 | 0.97–1.00 | 0.06 |
Use of vancomycine | |||
Not | 1 | ||
Yes | 4.56 | 0.71–29.38 | 0.11 |
Use of aminoside | |||
Not | 1 | ||
Yes | 2.74 | 0.32–23.24 | 0.36 |
VIH | |||
Not | 1 | ||
Yes | 0.96 | 0.55–1.78 | 0.98 |
Use of quinolone | |||
Not | 1 | ||
Yes | 0.39 | 0.07–2.23 | 0.29 |
Use of corticoids | |||
Not | 1 | ||
Yes | 1.32 | 0.18–9.6 | 0.78 |
Use of imidazole | |||
Not | 1 | ||
Yes | 0.89 | 0.31–2.61 | 0.84 |
Use of cephalosporins | |||
Not | 1 | ||
Yes | 0.7 | 0.16–2.75 | 3.00 |
Use of penicillin | |||
Not | 1 | ||
Yes | 0.94 | 0.3–2.94 | 0.92 |